National Childhood Vaccine Injury Act
National Childhood Vaccine Injury Act (NCVIA) is a federal law enacted by the United States Congress in 1986. The Act's primary goal is to ensure an adequate supply of vaccines, stabilize vaccine costs, and establish and maintain an accessible and efficient forum for individuals found to be injured by certain vaccines.
Background[edit]
The National Childhood Vaccine Injury Act was a response to a perceived crisis in vaccine supply in the United States in the early 1980s. Several factors contributed to this crisis, including increased litigation against vaccine manufacturers and providers. The Act was designed to stabilize the vaccine market by reducing the potential financial liability of vaccine manufacturers and providers.
Provisions[edit]
The Act has several key provisions. It established the National Vaccine Injury Compensation Program (VICP), a no-fault compensation program for individuals who are injured by vaccines. The VICP is funded by an excise tax on each dose of vaccine sold.
The Act also created the Vaccine Adverse Event Reporting System (VAERS), a national system for monitoring the safety of vaccines. VAERS collects and analyzes data on adverse events that occur after the administration of vaccines.
In addition, the Act requires health care providers to provide Vaccine Information Statements (VISs) to patients (or their parents or guardians) before administering each dose of certain vaccines. VISs provide information about the benefits and risks of vaccines.
Impact[edit]
The National Childhood Vaccine Injury Act has had a significant impact on the vaccine landscape in the United States. It has helped to ensure a stable supply of vaccines and has provided compensation to individuals who have been injured by vaccines. However, the Act has also been criticized for various reasons, including concerns about the fairness and efficiency of the VICP.
See also[edit]
References[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
